Skip to main content
All lobbying filings

FAEGRE DRINKER BIDDLE & REATH LLP

Lobbying for NATIONAL ASSOCIATION OF BOARDS OF PHARMACY · Association of member boards of pharmacy to protect public health

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $30,000.00 income · posted Apr 16, 2026

Official filing document

 Bills named in this filing 3
  • S 3794
    SAFE Drugs Act of 2026
  • HR 929
    Dr. Lorna Breen Health Care Provider Protection Reauthorization Act
  • HR 2483
    SUPPORT for Patients and Communities Reauthorization Act of 2025
 Lobbying activity 2
Health Issues

Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules; CMS DMEPOS accreditation program; S. 3794 SAFE Drugs Act.

Pharmacy

Medication safety; pharmacy regulation and licensure; drug supply chain security; prescription drug monitoring programs; and health provider workforce (HR 929 Dr. Lorna Breen Health Care Provider Protection Reauthorization Act). Combatting the opioid epidemic including ensuring MOUD access, DEA telehealth rules, and H.R. 2483 SUPPORT for Patients and Communities Reauthorization Act; CMS DMEPOS accreditation program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem